Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $0.51 in the prior trading day, IO Biotech Inc (NASDAQ: IOBT) closed at $0.5, down -2.76%. In other words, the price has decreased by -$2.76 from its previous closing price. On the day, 1.55 million shares were traded. IOBT stock price reached its highest trading level at $0.5146 during the session, while it also had its lowest trading level at $0.47.
Ratios:
Our goal is to gain a better understanding of IOBT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.96 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 5.26 whereas as Long-Term Debt/Eq ratio is at 4.77.
On September 30, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $0.39.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 30 ’25 when Hunter Heidi bought 15,000 shares for $1.39 per share. The transaction valued at 20,884 led to the insider holds 15,000 shares of the business.
Ahmad Qasim Iftikhar bought 31,350 shares of IOBT for $26,553 on Dec 23 ’24. The Chief Medical Officer now owns 31,350 shares after completing the transaction at $0.85 per share. On Dec 23 ’24, another insider, Zocca Mai-Britt, who serves as the Chief Executive Officer of the company, bought 12,500 shares for $0.81 each. As a result, the insider paid 10,120 and bolstered with 49,891 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOBT now has a Market Capitalization of 32966808 and an Enterprise Value of 13191809.
Stock Price History:
The Beta on a monthly basis for IOBT is 0.19, which has changed by -0.5145631 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, IOBT has reached a high of $2.79, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is -67.81%, while the 200-Day Moving Average is calculated to be -59.62%.
Shares Statistics:
The stock has traded on average 4.38M shares per day over the past 3-months and 7960210 shares per day over the last 10 days, according to various share statistics. A total of 65.88M shares are outstanding, with a floating share count of 49.27M. Insiders hold about 25.21% of the company’s shares, while institutions hold 20.21% stake in the company. Shares short for IOBT as of 1757894400 were 1067607 with a Short Ratio of 0.24, compared to 1755216000 on 1484024. Therefore, it implies a Short% of Shares Outstanding of 1067607 and a Short% of Float of 3.3800002000000005.
Earnings Estimates
The stock of IO Biotech Inc (IOBT) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.94 and -$0.94 for the fiscal current year, implying an average EPS of -$0.94. EPS for the following year is -$0.57, with 1.0 analysts recommending between -$0.57 and -$0.57.
